Skip to main content

Treatment of Dopamine Dysregulation Syndrome and Impulse Control Disorders in Parkinson’s Disease

  • Chapter
  • First Online:

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

Impulse control disorders (ICDs) related to Parkinson’s disease (PD) have been increasingly recognized since the initial descriptions more than a decade ago. While some of the initial descriptions of compulsive gambling, buying, sexual behavior, and eating were quite spectacular, awareness by both the patient/family and health-care communities has led to earlier recognition and management and fewer consequences. In addition to these behaviors, others include punding (stereotyped, repetitive, purposeless behaviors), compulsive medication use, or the dopamine dysregulation syndrome (DDS), and, more recently, the dopamine agonist withdrawal syndrome (DAWS) has been recognized and defined. Risk factors for these behaviors have included the use of dopamine agonists (DAs), male sex, younger age, a history of ICDs, and a personal or family history of substance abuse, bipolar disorder, or gambling problems. This chapter will review current and potential future strategies for the management of these psychiatric symptoms in the setting of PD. The case described is an extremely challenging clinical array of initial resistance to therapy and then dependence on dopamine replacement on the background of anxiety and depression. The 9-year history of her care is intended to illustrate the subtleties of this syndrome. Early, straightforward descriptions of addictive behaviors are referenced for further reading.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Suggested Reading

  • Driver-Dunckley E, Samanta J, Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson’s disease. Neurology. 2003;61:422–3.

    Article  CAS  Google Scholar 

  • Evans AH, Strafella AP, Weintraub D, Stacy M. Impulsive and compulsive behaviors in Parkinson’s disease. Mov Disord. 2009;24:1561–70.

    Article  Google Scholar 

  • Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science. 2007;318(5854):1309–12.

    Article  CAS  Google Scholar 

  • Napier TC, Corvol JC, Grace AA, Roitman JD, Rowe J, Voon V, Strafella AP. Linking neuroscience with modern concepts of impulse control disorders in Parkinson’s disease. Mov Disord. 2015;30(2):141–9.

    Article  Google Scholar 

  • Ricciardi L, Espay KJ, Krikorian R, Fasano A, Espay AJ. Dopamine dysregulation syndrome with psychosis in 24-hour intestinal levodopa infusion for Parkinson’s disease. Parkinsonism Relat Disord. 2016;28:152–4.

    Article  Google Scholar 

  • Samuel M, Rodriguez-Oroz M, Antonini A, Brotchie JM, Ray Chaudhuri K, Brown RG, Galpern WR, Nirenberg MJ, Okun MS, Lang AE. Management of impulse control disorders in Parkinson’s disease: controversies and future approaches. Mov Disord. 2015;30(2):150–9.

    Article  Google Scholar 

  • Vela L, Martínez Castrillo JC, García Ruiz P, Gasca-Salas C, Macías Macías Y, Pérez Fernández E, Ybot I, Lopez Valdés E, Kurtis MM, Posada Rodriguez IJ, Mata M, Ruiz Huete C, Eimil M, Borrue C, Del Val J, López-Manzanares L, Rojo Sebastian A, Marasescu R. The high prevalence of impulse control behaviors in patients with early-onset Parkinson’s disease: a cross-sectional multicenter study. J Neurol Sci. 2016;368:150–4.

    Article  CAS  Google Scholar 

  • Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, Whetteckey J, Wunderlich GR, Lang AE. Impulse control disorders in Parkinson’s disease: a cross-sectional study of dopaminergic therapy and other clinical features in 3,090 patients. Arch Neurol. 2010;67:589–95.

    Article  Google Scholar 

  • Weintraub D, David AS, Evans AH, Grant JE, Stacy M. Clinical spectrum of impulse control disorders in Parkinson’s disease. Mov Disord. 2015;30:121–7.

    Article  CAS  Google Scholar 

  • Weintraub D, Papay K, Xie SX. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. Neurology. 2015;84(13):1386–7.

    Article  Google Scholar 

  • Wingo TS, Evatt M, Scott B, Freeman A, Stacy M. Impulse control disorders arising in three patients treated with rotigotine. Clin Neuropharmacol. 2009;32:59–62.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark Stacy MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Stacy, M. (2019). Treatment of Dopamine Dysregulation Syndrome and Impulse Control Disorders in Parkinson’s Disease. In: Reich, S., Factor, S. (eds) Therapy of Movement Disorders. Current Clinical Neurology. Humana, Cham. https://doi.org/10.1007/978-3-319-97897-0_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-97897-0_30

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-319-97896-3

  • Online ISBN: 978-3-319-97897-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics